Titre:
  • Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Auteur:Cometta, Alain; Kern, Winfried V.; De Bock, Robrecht; Paesmans, Marianne; Vandenbergh, M; Crokaert, Françoise; Engelhard, Dan; Marchetti, Oscar; Akan, Hamdi; Skoutelis, Athanasios; Korten, V.; Vandercam, M; Gaya, Harold; Padmos, Andrew; Klastersky, Jean; Zinner, Stephen H.; Glauser, M. P.; Calandra, Thierry; Viscoli, Claudio; International Antimicrobial Therapy Group of the European Organization for Research Treatment of Cancer,
Informations sur la publication:Clinical infectious diseases, 37, 3, page (382-389)
Statut de publication:Publié, 2003-08
Sujet CREF:Cancérologie
MeSH keywords:Adolescent
Adult
Aged
Child
Child, Preschool
Double-Blind Method
Fever -- chemically induced -- drug therapy
Humans
Middle Aged
Neoplasms -- complications -- drug therapy -- physiopathology
Neutropenia -- etiology
Penicillanic Acid -- adverse effects -- analogs & derivatives -- therapeutic use
Piperacillin -- adverse effects -- therapeutic use
Treatment Outcome
Vancomycin -- therapeutic use
Note générale:Clinical Trial
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1058-4838
info:doi/10.1086/376637
info:pii/CID30844
info:scp/0042160270
info:pmid/12884163